The Team that will Deliver the
Most Advanced MRD Test
Dr. William Hanna
CEO
Dr. Hanna is a biotechnology scientist and entrepreneur in technologies covering therapeutics, molecular diagnostics, and genomics. Dr. Hanna recently co-founded Radian Biotechnology to develop next generation nucleic acid technologies for Liquid Biopsies in the emerging field of Personalized Cancer Genomics. Previously he was at Gen-Probe, then the nation’s largest stand alone DNA Diagnostics company. There he was technical lead in the Cancer Group and the Technology Assessment Group. He was Director of Assay Development at Biological Dynamics, and Radian Biotechnology.
He received a B.S. in Biology from Northern Illinois University and a Ph.D. in Microbiology/Immunology from the University of Illinois at Chicago.
Sherman Lin
Founder
Owner and Clinical Director of the S. Lin Dental Clinic in San Diego, California. He graduated Boston College with BS in Biology (1984). He received his Doctor of Dental Surgery at University of Southern California (1991). He is an international lecturer for Implantology.
Alexander Yum
CTO
Alexander is the head bio-technician for CYMD. He attended University of Nevada with bachelor degree in biological sciences. He started as a technology manager with the purpose of developing detection technologies for infectious diseases such as chlamydia, gonorrhea, HIV-1, ZIKA, and various forms of cancer. He oversees all the college interns and directs them through various experiments involving PCR, RNA and DNA purification, and probe tests. He is in charge of overseeing quality control to insure the reliability of all the research tests. He is an assay development specialist and analytical lab technician.
Joey Park
Chief Accounting Officer
Joey is responsible for overseeing all accounting functions: sales management, financial statements, product design, and operations of cost control systems. She reviews all documents and contracts regarding financial reporting and transaction accounting. She also is involved in tax compliance and strategy and overall company’s performance. She graduated from Otis Parsons Art and Design.
Jenevine Yum
UI/UX Designer
Experience Designer with a demonstrated history of working in the marketing and web development industry. Skilled in UI/UX design, wireframing/prototyping, WordPress, Adobe Creative Suite, Webflow platform, Graphic Design, and Web Design. Strong arts and design professional with a Bachelor of Arts (B.A.) focused in Graphic Design from University of Nevada-Las Vegas.
Board of Advisors
Richard Brand
CFO Circulogene
Dad died of cancer. Mom survived cancer. The business of health care is personal for me. My prior company was the best performing biotech IPO for much of 2017. My recent company raised $86 million in Series B.
Federico Goodsaid
Federico was previously Associate Director for Operations in Genomics and Biomarker Qualification Coordinator at the Office of Clinical Pharmacology/Office of Translational Sciences/ Center for Drug Evaluation and Research/ U.S. FDA, working on the regulatory application and development of genomics and biomarkers at the FDA.
Before he joined the FDA, he was Senior Staff Scientist at Applied Biosystems and Lead for the Molecular Toxicology Group at theSchering-Plough Research Institute.
Cheng-Yao Chen
Scientific Adviser and Consultant
Dr. Chen is an expert in emerging, molecular technology development, and has more than 15-years of protein biochemistry and engineering experience. Dr. Chen was a staff scientist at Illumina responsible for leading internal R&D projects in advanced DNA sequencing and gene synthesis technologies. He is also an inventor in a new gene synthesis method for creating artificial DNAs. Before Illumina, Dr. Chen was a key research scientist at Life Technologies in creating a FRET-based, real-time, single-molecule sequencing platform. Dr. Chen earned his Ph.D. in Molecular & Cellular Biology from Oregon State University in Corvallis, Oregon; M.S. in Clinical Laboratory Sciences from S.U.N.Y. at Buffalo in Buffalo, New York; B.S. in Medical Technologies from Taipei Medical University in Taipei, Taiwan. He has 10 publications and 12 pending/granted patents in new qPCR methods, DNA sequencing technologies, and various enzyme development.
